|
Jun 25
|
Appili Therapeutics Reports Fiscal Year 2025 Financial and Operational Results
|
|
May 19
|
Appili Therapeutics Provides Update on Arrangement with Aditxt, Inc.
|
|
Apr 2
|
Appili President and CEO, Don Cilla to Join Aditxt CEO, Amro Albanna for Aditxt Weekly Update on April 4, 2025
|
|
Oct 3
|
Aditxt Delivers Shareholder Update and 2024 Year-End Plan
|
|
Aug 29
|
Aditxt to Present at the H.C. Wainwright 26th Annual Global Investment Conference September 9th-11th, 2024
|
|
Jul 25
|
Aditxt Signs Second Amendment to the Arrangement Agreement with Appili Therapeutics, Targeting September 30 Closing of the Acquisition
|
|
Dec 6
|
APLIF: ATI-1701 Program Awarded Additional US$6.6 Million in Funding…
|
|
Aug 11
|
Appili Therapeutics Reports Financial and Operational Results for First Quarter of Fiscal Year 2024
|